Archford Capital Strategies’s Pediatrix Medical MD Stock Holding History

Archford Capital Strategies’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48	Closed	-$1K	–	566
2019 Q1	$1K	Hold	48	–	–	﹤0.01%	512
2018 Q4	$2K	Hold	48	–	–	﹤0.01%	466
2018 Q3	$2K	Hold	48	–	–	﹤0.01%	496
2018 Q2	$2K	Hold	48	–	–	﹤0.01%	588
2018 Q1	$3K	Buy	+48	New	+$2.63K	﹤0.01%	468
2017 Q2	–	Sell	-48	Closed	-$3K	–	450
2017 Q1	$3K	Hold	48	–	–	﹤0.01%	549
2016 Q4	$3K	Sell	48 -30	-38%	-$1.95K	﹤0.01%	466
2016 Q3	$4K	Sell	78 -78	-50%	-$5.33K	﹤0.01%	436
2016 Q2	$11K	Buy	+156	New	+$10.7K	0.01%	384
2016 Q1	–	Sell	-192	Closed	-$15K	–	427
2015 Q4	$15K	Hold	192	–	–	0.01%	406
2015 Q3	$15K	Buy	192 +96	+100%	+$7.75K	0.01%	302
2015 Q2	$8K	Sell	96 -9	-9%	-$648	0.01%	344
2015 Q1	$7.61K	Hold	105	–	–	0.01%	358
2014 Q4	$7K	Hold	105	–	–	0.01%	378
2014 Q3	$6K	Sell	105 -14	-12%	-$794	﹤0.01%	388
2014 Q2	$6.92K	Buy	119 +71	+148%	+$4.18K	0.01%	472
2014 Q1	$2.98K	Buy	+48	New	+$2.79K	﹤0.01%	590

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Archford Capital Strategies's MD Position: Q2 2019 in Review

Archford Capital Strategies sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 48 shares — an estimated $1K sold.

Archford Capital Strategies first reported a position in MD in Q1 2014 and held it in 17 quarters. The position peaked at $15K in Q4 2015. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

Archford Capital Strategies reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
Archford Capital Strategies sold 48 Pediatrix Medical shares in Q2 2019, an estimated $1K.
Archford Capital Strategies first reported a position in Pediatrix Medical in Q1 2014 and held it in 17 quarters.
Archford Capital Strategies's Pediatrix Medical position peaked at $15K in Q4 2015.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Archford Capital Strategies's 13F filing for Q2 2019, filed 18 Jul 2019.